Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trouw

Showing results (221-230 of 283) with videos related to

Pageof 29
Sort By:
RMD Open|December 20, 2023
Type 17-specific immune pathways are active in early spondyloarthritisCatherine D Hughes, Sarah E Ryan, Kathryn J A Steel, et al.
Annals of the Rheumatic Diseases|October 15, 2011
The ACPA recognition profile and subgrouping of ACPA-positive RA patientsAnnemiek Willemze, Stefan Böhringer, Rachel Knevel, et al.
Nature Communications|July 20, 2019
Single-cell reconstruction of follicular remodeling in the human adult ovaryX Fan, M Bialecka, I Moustakas, et al.
Rheumatology (Oxford, England)|October 14, 2004
A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosusM A Seelen, E A van der Bijl, L A Trouw, et al.
Osteoarthritis and Cartilage|October 22, 2019
Complement component C1q is produced by isolated articular chondrocytesR Lubbers, R A van Schaarenburg, J C Kwekkeboom, et al.
Arthritis Research & Therapy|January 20, 2019
In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment responseEmma C de Moel, Veerle F A M Derksen, Leendert A Trouw, et al.
RMD Open|December 6, 2023
Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II associationMichelle D van den Beukel, Tineke J van Wesemael, Anna Titia W Hoogslag, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigensP Suwannalai, H U Scherer, D van der Woude, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|January 21, 2025
Evaluation of anti-citrullinated and anti-carbamylated antibodies in mexicans with rheumatoid arthritis and at-risk individualsEdgar E Lara-Ramírez, Betzaida Cuevas-Córdoba, Diana Olguín-Calderon, et al.
Arthritis Research & Therapy|February 28, 2018
Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomesEmma C de Moel, Veerle F A M Derksen, Gerrie Stoeken, et al.
Pageof 29

Showing results (221-230 of 283) with videos related to

Sort By:
Pageof 29
RMD Open|December 20, 2023
Type 17-specific immune pathways are active in early spondyloarthritisCatherine D Hughes, Sarah E Ryan, Kathryn J A Steel, et al.
Annals of the Rheumatic Diseases|October 15, 2011
The ACPA recognition profile and subgrouping of ACPA-positive RA patientsAnnemiek Willemze, Stefan Böhringer, Rachel Knevel, et al.
Nature Communications|July 20, 2019
Single-cell reconstruction of follicular remodeling in the human adult ovaryX Fan, M Bialecka, I Moustakas, et al.
Rheumatology (Oxford, England)|October 14, 2004
A role for mannose-binding lectin dysfunction in generation of autoantibodies in systemic lupus erythematosusM A Seelen, E A van der Bijl, L A Trouw, et al.
Osteoarthritis and Cartilage|October 22, 2019
Complement component C1q is produced by isolated articular chondrocytesR Lubbers, R A van Schaarenburg, J C Kwekkeboom, et al.
Arthritis Research & Therapy|January 20, 2019
In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment responseEmma C de Moel, Veerle F A M Derksen, Leendert A Trouw, et al.
RMD Open|December 6, 2023
Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II associationMichelle D van den Beukel, Tineke J van Wesemael, Anna Titia W Hoogslag, et al.
Annals of the Rheumatic Diseases|November 12, 2010
Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigensP Suwannalai, H U Scherer, D van der Woude, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|January 21, 2025
Evaluation of anti-citrullinated and anti-carbamylated antibodies in mexicans with rheumatoid arthritis and at-risk individualsEdgar E Lara-Ramírez, Betzaida Cuevas-Córdoba, Diana Olguín-Calderon, et al.
Arthritis Research & Therapy|February 28, 2018
Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomesEmma C de Moel, Veerle F A M Derksen, Gerrie Stoeken, et al.
Pageof 29